OpenEvidence
Medical information and clinical decision-support company providing an AI platform that synthesizes peer-reviewed research, guidelines and licensed medical content for clinicians.
$15B*25.0%increase
AI valuation
$0
$5B
$10B
$15B
$20B
$1B
Feb 20, 2025
$3.5B
Jul 15, 2025
$6B
Oct 20, 2025
$12B
Jan 21, 2026
$15B
Sep 28, 2026
2026
Financial events
| Date | Event | Type | Figures | Source |
|---|---|---|---|---|
| Sep 28, 2026 | OpenEvidence confirms additional $250M funding | Funding round | $250M raised | Becker's Hospital Review |
| Jan 21, 2026 | OpenEvidence surpasses $100M annual revenue | Revenue disclosure | $100M Annual revenue disclosed January 2026 | TechCrunch |
| Jan 21, 2026 | OpenEvidence raises $250M Series D | Funding round | $250M raised | TechCrunch |
| Oct 20, 2025 | OpenEvidence raises $200M Series C | Funding round | $200M raised | Axios |
| Jul 15, 2025 | OpenEvidence raises $210M Series B | Funding round | $210M raised | OpenEvidence |
| Feb 20, 2025 | OpenEvidence raises $75M Series A | Funding round | $75M raised | Axios |
* Market cap / valuation. Company values are AI-attributed: the latest market cap or valuation × the share attributed to AI (100% for pure AI companies). Methodology